PureCycle Technologies

PCTNASDAQUSD

THESIS ALERT

Email me when the PCT thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$2.00
−$0.13 (−6.10%)Today 1M −45.66%
After hours$2.06+2.93%

Updated Nov 11, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$2.13
Prior regular-session close from the quote source.
$1.96–$2.21
Regular-session low and high so far today.
5.5M
Regular-session shares traded · Nov 11, 4:00 PM ET.
Feb 25 projected
Projected for 2027-02-25 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
$1.60–$14.20
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own PCT if PureCycle can create durable value by converting municipal/industrial polypropylene waste into a branded, premium recycled polypropylene (PureFive) at commercial scale, capturing price premiums and long-term offtakes as regulatory and brand demand forces recycled-content adoption.

PCT price history

Latest price$2.00Today−$0.13 (-6.10%)
PCT -45.28%S&P 500 -2.42%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

4 MATERIAL PROPOSITIONS
  • Successful commissioning and ramp of Purification/Feed PreP plants will convert installed capacity into recurring resin sales, driving material revenue growth.HoldingMateriality: High

    FY2025 Revenues of 8,355,000 USD (first non-zero annual revenue after prior years at 0) show initial commercial sales tied to plant activity. If plants ramp, revenue scales and the company can demonstrate unit economics; if they do not, the business remains a capital-consuming prototype and share value collapses.

    Watch: Feedstock supply interruptions or local feedstock price spikes that limit throughput (raw material price risk described in MD&A).

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    FY2025 Revenues of 8,355,000 USD (first non-zero annual revenue after prior years at 0) show initial commercial sales tied to.

    Open source ↗
  • Achieving scale at multiple purification plants will materially reduce per-unit production costs and convert large operating losses toward breakeven (operating income improvement) as fixed costs spread and process yields improve.WeakeningMateriality: High

    Large asset base increases (assets rose toward 922,666,000 USD in FY2025) consistent with capital deployed to build capacity that should enable scale economics. Margin recovery determines whether revenue growth becomes cash-generative or merely increases capital requirements; failure to reduce operating losses means perpetual dilution or restructuring.

    Watch: Sustained low crude oil/virgin-PP prices that make virgin resin materially cheaper than recycled resin, compressing margins (commodity market risk in MD&A).

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Large asset base increases (assets rose toward 922,666,000 USD in FY2025) consistent with capital deployed to build capacity that should.

    Open source ↗
  • Existing cash balances must fund the near-term ramp; without material positive operating cash flow or new financing, the company will need to raise capital or slow projects.StrengtheningMateriality: Medium

    Cash and cash equivalents of 156,694,000 USD at 2025 year-end. If cash is sufficient for the planned ramp, management can execute; if not, equity dilution, project delays, or asset sales are likely and would damage value for existing shareholders.

    Watch: Inability to access capital markets on acceptable terms (market sentiment or equity dilution risk).

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

  • Regulatory mandates for recycled content and corporate sustainability commitments will sustain baseline demand and allow PureFive to command a pricing premium versus commodity virgin polypropylene.HoldingMateriality: Medium

    MD&A cites 'shifting market expectations toward sustainable sourcing' and 'certain regulatory developments in support of plastic recycling' as demand supports. Regulatory and brand-driven demand reduces price elasticity and defends margins; absent such tailwinds, PureCycle competes mainly on cost with commodity virgin PP.

    Watch: Delays, rollbacks, or weaker-than-expected scope in recycled-content mandates from key jurisdictions.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    MD&A cites 'shifting market expectations toward sustainable sourcing' and 'certain regulatory developments in support of plastic recycling' as demand supports.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Successful commissioning and ramp of Purification/Feed PreP plants will convert installed capacity into recurring resin sales, driving material revenue growth. If plants ramp, revenue scales and the company can demonstrate unit economics; if they do not, the business remains a capital-consuming prototype and share value collapses.

Achieving scale at multiple purification plants will materially reduce per-unit production costs and convert large operating losses toward breakeven (operating income improvement) as fixed costs spread and process yields improve. Margin recovery determines whether revenue growth becomes cash-generative or merely increases capital requirements; failure to reduce operating losses means perpetual dilution or restructuring.

Existing cash balances must fund the near-term ramp; without material positive operating cash flow or new financing, the company will need to raise capital or slow projects. If cash is sufficient for the planned ramp, management can execute; if not, equity dilution, project delays, or asset sales are likely and would damage value for existing shareholders.

Regulatory mandates for recycled content and corporate sustainability commitments will sustain baseline demand and allow PureFive to command a pricing premium versus commodity virgin polypropylene. Regulatory and brand-driven demand reduces price elasticity and defends margins; absent such tailwinds, PureCycle competes mainly on cost with commodity virgin PP.

All standing thesis claims
Original report summary

PureCycle can create durable value by converting municipal/industrial polypropylene waste into a branded, premium recycled polypropylene (PureFive) at commercial scale, capturing price premiums and long-term offtakes as regulatory and brand demand forces recycled-content adoption.

Evidence assessed Nov 10, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for PureCycle Technologies

Where the evidence on PureCycle Technologies disagrees: Mixed on the latest evidence (Nov 10, 2026). Of its 4 thesis points, 1 strengthening, 2 holding and 1 weakening.

Bull case: what the evidence supports

  • Successful commissioning and ramp of Purification/Feed PreP plants will convert installed capacity into recurring resin sales, driving material revenue growth.

    sec.gov ↗

  • Existing cash balances must fund the near-term ramp; without material positive operating cash flow or new financing, the company will need to raise capital or slow projects.

  • Regulatory mandates for recycled content and corporate sustainability commitments will sustain baseline demand and allow PureFive to command a pricing premium versus commodity virgin polypropylene.

    sec.gov ↗

Bear case: what the evidence questions

  • Achieving scale at multiple purification plants will materially reduce per-unit production costs and convert large operating losses toward breakeven (operating income improvement) as fixed costs spread and process yields improve.

    sec.gov ↗

Thesis-Break Engine

What has broken in PureCycle Technologies’s thesis

Each break OptimistFi flagged on PureCycle Technologies, dated — with what has historically followed the same kind of break across the market, not a forecast for PureCycle Technologies.

peers+15%-20%-2%12 mo agonow+6 mo
Daily price, then where similar breaks led across the market: the typical -2% path vs comparable companies over six months, inside the middle-half range (+15% to -20%). A base rate, not a forecast.
  • CEO / officer changecondition set before this filing

    Across all companies, this kind of break has happened 16,849 times before. Those stocks trailed comparable companies by a median of 2% over the next six months, and 38% of them trailed it by 10 points or more.

How the Thesis-Break Engine works →Historical outcomes are measured against comparable companies after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Reported results of operations (earnings release).

    PureCycle Technologies filed an SEC 8-K on 2026-11-04: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

  2. Mixed
    Entered a material definitive agreement.

    PureCycle Technologies filed an SEC 8-K on 2026-08-31: Entered a material definitive agreement. It is a dated development that tests the current thesis.

  3. Mixed
    Reported results of operations (earnings release).

    PureCycle Technologies filed an SEC 8-K on 2026-08-06: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • Feedstock supply interruptions or local feedstock price spikes that limit throughput (raw material price risk described in MD&A).
  • Sustained low crude oil/virgin-PP prices that make virgin resin materially cheaper than recycled resin, compressing margins (commodity market risk in MD&A).
  • Inability to access capital markets on acceptable terms (market sentiment or equity dilution risk).
  • Delays, rollbacks, or weaker-than-expected scope in recycled-content mandates from key jurisdictions.

PCT news

Loading headlines…

Financial statements

PCT income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

PCT: quick answers

When does PureCycle Technologies (PCT) report earnings next?
PureCycle Technologies's next results are projected for February 25, 2027, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on November 4, 2026. Earnings calendar
What is PCT's short interest?
As of October 30, 2026, 69.3M PCT shares were sold short, 34.5% of its shares outstanding, up 6.2% from the count before. At the stock's average daily volume that is 11 days to cover. FINRA publishes the count twice a month. PCT short interest history
Which well-known investors own PCT?
1 of the 37 well-known funds tracked here reported PCT shares in their latest 13F filing. By share of the fund's portfolio: Duquesne Family Office (Stanley Druckenmiller), 0.4%. Fund portfolios

PCT in well-known investors’ portfolios

1 of 37 funds reported PCT shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.

FundOf its portfolioValueChangeQuarter
Stanley DruckenmillerDuquesne Family Office0.42%$21.7M+178.4%Q2 2026

Every fund’s portfolio

ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.